pharma · MASH · MASLD · SGMT
Sagimet Biosciences
Sagimet Biosciences clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 155 Bovet Rd, Suite 303, San Mateo, California 94402, US
- Employees
- 27
- Programs
- 12
- Drugs
- 4
- Patents
- 1
Sagimet Biosciences projects
6 ClinicalTrials.gov programs sponsored by Sagimet Biosciences.
Sagimet Biosciences has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Denifanstat
Sagimet Biosciences
Healthy
1 trial -
TVB-2640
Sagimet Biosciences
Prostatic Neoplasms, Castration-Resistant
1 trial -
TVB-2640
Sagimet Biosciences
Solid Malignant Tumor
1 trial -
TVB-2640 - 50 mg
Sagimet Biosciences
Non-alcoholic Steatohepatitis
1 trial -
TVB-3567
Sagimet Biosciences
Acne
1 trial -
[14C]-TVB-2640
Sagimet Biosciences
Healthy Volunteers
1 trial
Frequently asked questions
How many clinical projects does Sagimet Biosciences have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.